Respironics has launched BiPAP autoSV, a FDA approved device intended to provide noninvasive ventilatory support to treat adult patients with Obstructive Sleep Apnea (OSA) and Respiratory Insufficiency caused by central and/or mixed apneas and periodic breathing.
What is Sleep Apnea?
During a normal sleep cycle, you fall asleep in stages. Your body goes through five sleep stages that begin with drowsiness, advancing to a light sleep, drifting into a deep sleep, and ending in the fifth stage called Rapid Eye Movement (REM). If you have sleep apnea, your body stops breathing for a few seconds during this sleep cycle. Your system signals that there is a lack of oxygen and jolts you awake to kick start your breathing. So, your body has to start the sleep cycle again. This may leave you feeling very tired the next day.
You may not even notice or remember that you awoke during the night because it happened so quickly, but in most sleep apnea sufferers, breathing starts and stops several times. Some patients can even experience hundreds of episodes a night. Untreated, sleep apnea can cause high blood pressure and other cardiovascular disease, memory problems, weight gain, impotency, and headaches.
Solution: The BiPAP autoSV device delivers optimal therapy for these complicated sleep-disordered breathing patients utilizing a multi-level algorithm. On a breath-by-breath basis, the revolutionary algorithm utilizes Respironics’ core technologies to adjust pressure support upon detecting a sleep event, such as an apnea, hypopnea or periodic breathing, to stabilize the patient’s breathing pattern. This algorithm also calculates the patient’s spontaneous breathing rate and will automatically trigger a breath for the patient should a sleep event occur.
Via: Compliancehome
